Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 33.03B | 26.68B | 27.46B | 27.57B | 30.12B | 38.41B |
Gross Profit | 5.03B | 3.78B | 3.19B | 4.36B | 3.05B | 3.52B |
EBITDA | 1.05B | 2.57B | 369.13M | 2.61B | 1.34B | 1.79B |
Net Income | 7.40B | 740.70M | -519.89M | 885.50M | -116.83M | 184.00M |
Balance Sheet | ||||||
Total Assets | 48.29B | 29.63B | 29.08B | 32.77B | 32.34B | 29.62B |
Cash, Cash Equivalents and Short-Term Investments | 5.77B | 3.64B | 2.80B | 5.14B | 5.91B | 2.56B |
Total Debt | 6.80B | 4.82B | 5.43B | 8.35B | 9.94B | 7.58B |
Total Liabilities | 25.05B | 13.93B | 13.89B | 17.79B | 18.55B | 15.98B |
Stockholders Equity | 21.43B | 14.50B | 14.15B | 13.98B | 12.92B | 12.65B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 889.58M | -20.02M | 824.08M | 871.87M | 438.00M |
Operating Cash Flow | 0.00 | 1.52B | 993.15M | 1.29B | 1.76B | 2.15B |
Investing Cash Flow | 0.00 | 191.69M | -698.65M | -366.67M | -721.52M | -1.73B |
Financing Cash Flow | 0.00 | -896.77M | -3.17B | -1.77B | 2.34B | -708.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥48.85B | 10.21 | 4.64% | 6.35% | 11.03% | ||
79 Outperform | ¥56.73B | 5.26 | 4.75% | 4.12% | 192.18% | ||
78 Outperform | ¥33.06B | 3.52 | 4.20% | 0.79% | 104.86% | ||
77 Outperform | ¥98.87B | 10.51 | 4.55% | 7.39% | 15.07% | ||
75 Outperform | ¥17.88B | 6.99 | 4.53% | 0.79% | 60.97% | ||
73 Outperform | ¥5.18B | 1.03 | 3.03% | 42.12% | 578.59% | ||
44 Neutral | C$964.86M | -6.72 | -13.73% | 2.52% | 17.53% | -32.55% |